After a Long Fight to Survive, Genta Incorporated (GETA.OB) Files for Chapter 7
8/2/2012 8:38:31 AM
More...
|
Genta Incorporated (GETA.OB) to Present at 2012 Biotechnology Industry Organization (BIO) International
6/18/2012 9:35:16 AM
More...
|
Genta Incorporated (GETA.OB) Announces Agreement With FDA on Special Protocol Assessment of Phase 3 Trial of Tesetaxel as Initial Chemotherapy for Women With Metastatic Breast Cancer
6/18/2012 9:34:20 AM
More...
|
Genta Incorporated (GETA.OB) Initiates Randomized Trial of Tesetaxel as First-Line Therapy for Women With Recurrent Breast Cancer
5/31/2012 9:39:31 AM
More...
|
Genta Incorporated (GETA.OB) Announces Results of Tesetaxel Confirmatory Trial in Patients With Advanced Gastric Cancer
5/24/2012 9:59:28 AM
More...
|
Genta Incorporated (GETA.OB) Release:Tesetaxel Results as Initial Chemotherapy for Women With Recurrent Breast Cancer to be Highlighted at American Society of Clinical Oncology
5/22/2012 9:52:27 AM
More...
|
Genta Incorporated (GETA.OB) Reports First Quarter 2012 Financial Results
5/14/2012 9:47:46 AM
More...
|
Genta Incorporated (GETA.OB) Initiates Randomized Trial of Tesetaxel in Gastric Cancer
5/8/2012 9:32:29 AM
More...
|
Genta Incorporated (GETA.OB) Release: Tesetaxel Clinical Data in Gastric Cancer and Breast Cancer to be Featured at American Society of Clinical Oncology Annual Meeting
4/4/2012 9:27:41 AM
More...
|
Genta Incorporated (GETA.OB) Completes Financing of Up to $12 Million
3/29/2012 7:02:43 AM
More...
|
|